NKE
42
2
WRK
75
2
EMN
76
4
PWR
74
3
ETN
83
4
ROP
65
2
CRM
49
2
LLY
60
-7
DE
39
3
NI
55
2
HAS
53
2
ADM
34
-2
JNPR
49
6
PX
25
6
TGNA
56
3
HBAN
56
2
ITW
59
3
ADSK
52
4
FFIV
58
2
DO
69
9
NKE
42
2
WRK
75
2
EMN
76
4
PWR
74
3
ETN
83
4
ROP
65
2
CRM
49
2
LLY
60
-7
DE
39
3
NI
55
2
HAS
53
2
ADM
34
-2
JNPR
49
6
PX
25
6
TGNA
56
3
HBAN
56
2
ITW
59
3
ADSK
52
4
FFIV
58
2
DO
69
9
Financhill
Back

Leap Therapeutics Quote, Financials, Valuation and Earnings

Election Shock on August 19th?

Click here now to see the evidence I've gathered.
Buy
63

LPTX
Leap Therapeutics

Last Price:
3.23
Seasonality Move:
-4.93%

7 Day Trial

ALL ACCESS PASS

$ 7

I love this overnight trade happening Thursday

Access my free presentation on these overnight trades right here

Leap Therapeutics Price Quote

$3.23
+0.04 (+3.19%)
(Updated: May 4, 2024 at 6:26 AM ET)

Leap Therapeutics Key Stats

Buy
63
Leap Therapeutics (LPTX) is a Buy
Day range:
$3.01 - $3.28
52-week range:
$1.24 - $10.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
43.43
P/B ratio:
1.36%
Volume:
334.6K
Avg. volume:
424.4K
1-year change:
-13.92%
Market cap:
$81.7M
Revenue:
$0
EPS:
$-4.82

How Much Does Leap Therapeutics Make?

Data Unavailable

Is Leap Therapeutics Growing As A Company?

Data Unavailable

Leap Therapeutics Stock Price Performance

What Is Leap Therapeutics 52-Week High & Low?

Leap Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Leap Therapeutics?

  • How Much Debt Does Leap Therapeutics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Leap Therapeutics Have?
    Cash and short term investments quarterly total is $70.6M
  • What Is Leap Therapeutics’s Book Value Per Share?
    Book value per share is 2.35

Is Leap Therapeutics Cash Flow Positive?

  • What Is LPTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$43.8M
  • What Is Leap Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$30K
  • What Is Leap Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $49M

Leap Therapeutics Return On Invested Capital

Data Unavailable

Leap Therapeutics Earnings Date & Stock Price

Leap Therapeutics Competitors

  • Who Are Leap Therapeutics's Competitors?
    Below is a list of companies who compete with Leap Therapeutics or are related in some way:
    • AIM ImmunoTech Inc (AIM)
    • Armata Pharmaceuticals Inc (ARMP)
    • Cutera Inc (CUTR)
    • OrthoPediatrics Corp (KIDS)
    • Protalix BioTherapeutics Inc (PLX)

Leap Therapeutics Dividend Yield

Data Unavailable

Leap Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 64.5%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 11.75
Upside from Last Price: 268.34%

Major Shareholders

  • How many LPTX shares are owned by institutional investors?
    7.7M LPTX shares are owned by institutional investors
  • How many LPTX shares are owned by insiders?
    93.8K LPTX shares are owned by insiders